James B. Arnett
FDA investigator
Appears on 2 documents from 2021 to 2022, mostly at sites in Arizona. Most often cites stability testing (21 CFR 211.166(a)).
- 2
- Documents on file
- 5.0
- Observations per 483
- 2021
- First seen
- 2022
- Most recent
What they cite most
From 10 observations- 21 CFR 211.166(a)Stability testing4
- FDCA 501(a)(2)(A)Insanitary conditions3
- 21 CFR 211.165(a)Testing and release for distribution2
- 21 CFR 211.160(b)(4)General requirements1
Activity by year
2021: 1, 2022: 1
Where
Arizona 1 · California 1
Often inspects with
Is James B. Arnett coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-04-15 | 483 Lynn Oaks Compounding PharmacyApr 15, 2022 · California | California | 7 | |
| 2021-07-29 | 483 Enemeez, LLC dba Summit PharmaceuticalsJul 29, 2021 · Phoenix, Arizona | Phoenix, Arizona | 3 |
About this profile
What does James B. Arnett inspect?
James B. Arnett appears on 2 documents on file covering 2 sites, mostly in Arizona.
What do they cite most often?
21 CFR 211.166(a) (stability testing), followed by FDCA 501(a)(2)(A) and 21 CFR 211.165(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for James B. Arnett is dated Apr 15, 2022.